In medical trials, the incidence of opportunistic infections was very similar in people working with immunosuppressive regimens with or without Simulect. Within a pooled analysis of two five-calendar year extension reports, no variations had been present in the incidence of malignancies and LPDs in between immunosuppressive regimens with or without